SEC Form 4 · accession 0001209191-15-024978
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Isan Chen
Officer — Chief Medical & Dev't Officer
Period of report
Mar 9, 2015
Accepted (ET)
Mar 11, 2015 · 11:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 9, 2015 | M | 12,666 | $15.79 | A | 12,666 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $15.79 | Mar 9, 2015 | M | 12,666 | D | — | Nov 7, 2023 | Common Stock | 12,666 | 109,334 | D |
Explanation of responses
- F11/4th of the shares subject to the Option vested and became exercisable on September 1, 2014, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.